Literature DB >> 32443573

Outcomes after Complicated and Uncomplicated Mild Traumatic Brain Injury at Three-and Six-Months Post-Injury: Results from the CENTER-TBI Study.

Daphne C Voormolen1, Marina Zeldovich2, Juanita A Haagsma1,3, Suzanne Polinder1, Sarah Friedrich4, Andrew I R Maas5,6, Lindsay Wilson7, Ewout W Steyerberg1,8, Amra Covic2, Nada Andelic9,10, Anne Marie Plass2, Yi-Jhen Wu2, Thomas Asendorf4, Nicole von Steinbüechel2, Center-Tbi Center-Tbi Participants Investigators.   

Abstract

The objective of this study was to provide a comprehensive examination of the relation of complicated and uncomplicated mild traumatic brain injury (mTBI) with multidimensional outcomes at three- and six-months after TBI. We analyzed data from the Collaborative European NeuroTrauma Effectiveness Research (CENTER-TBI) research project. Patients after mTBI (Glasgow Coma scale (GCS) score of 13-15) enrolled in the study were differentiated into two groups based on computed tomography (CT) findings: complicated mTBI (presence of any traumatic intracranial injury on first CT) and uncomplicated mTBI (absence of any traumatic intracranial injury on first CT). Multidimensional outcomes were assessed using seven instruments measuring generic and disease-specific health-related quality of life (HRQoL) (SF-36 and QOLIBRI), functional outcome (GOSE), and psycho-social domains including symptoms of post-traumatic stress disorder (PTSD) (PCL-5), depression (PHQ-9), and anxiety (GAD-7). Data were analyzed using a multivariate repeated measures approach (MANOVA-RM), which inspected mTBI groups at three- and six-months post injury. Patients after complicated mTBI had significantly lower GOSE scores, reported lower physical and mental component summary scores based on the SF-36 version 2, and showed significantly lower HRQoL measured by QOLIBRI compared to those after uncomplicated mTBI. There was no difference between mTBI groups when looking at psychological outcomes, however, a slight improvement in PTSD symptoms and depression was observed for the entire sample from three to six months. Patients after complicated mTBI reported lower generic and disease specific HRQoL and worse functional outcome compared to individuals after uncomplicated mTBI at three and six months. Both groups showed a tendency to improve from three to six months after TBI. The complicated mTBI group included more patients with an impaired long-term outcome than the uncomplicated group. Nevertheless, patients, clinicians, researchers, and decisions-makers in health care should take account of the short and long-term impact on outcome for patients after both uncomplicated and complicated mTBI.

Entities:  

Keywords:  Traumatic brain injury; complicated mild traumatic brain injury; functional outcome; generic and disease-specific health-related quality of life; outcome

Year:  2020        PMID: 32443573     DOI: 10.3390/jcm9051525

Source DB:  PubMed          Journal:  J Clin Med        ISSN: 2077-0383            Impact factor:   4.241


  4 in total

Review 1.  Developing Biomarkers of Mild Traumatic Brain Injury: Promise and Progress of CNS-Derived Exosomes.

Authors:  Melonie N Vaughn; Charisse N Winston; Natalie Levin; Robert A Rissman; Victoria B Risbrough
Journal:  Front Neurol       Date:  2022-02-10       Impact factor: 4.003

2.  Employment and Economic Outcomes of Participants With Mild Traumatic Brain Injury in the TRACK-TBI Study.

Authors:  Étienne Gaudette; Seth A Seabury; Nancy Temkin; Jason Barber; Anthony M DiGiorgio; Amy J Markowitz; Geoffrey T Manley
Journal:  JAMA Netw Open       Date:  2022-06-01

3.  An interpretable neural network for outcome prediction in traumatic brain injury.

Authors:  Cristian Minoccheri; Craig A Williamson; Mark Hemmila; Kevin Ward; Erica B Stein; Jonathan Gryak; Kayvan Najarian
Journal:  BMC Med Inform Decis Mak       Date:  2022-08-01       Impact factor: 3.298

4.  Post-Concussion Symptoms Rule: Derivation and Validation of a Clinical Decision Rule for Early Prediction of Persistent Symptoms after a Mild Traumatic Brain Injury.

Authors:  Natalie Le Sage; Jean-Marc Chauny; Simon Berthelot; Patrick Archambault; Xavier Neveu; Lynne Moore; Valérie Boucher; Jérôme Frenette; Élaine De Guise; Marie-Christine Ouellet; Jacques Lee; Andrew D McRae; Eddy Lang; Marcel Émond; Éric Mercier; Pier-Alexandre Tardif; Bonnie Swaine; Peter Cameron; Jeffrey J Perry
Journal:  J Neurotrauma       Date:  2022-09-09       Impact factor: 4.869

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.